Trial Details

UNKNOWN
Basic Information
Clinical ID c1368
Identifier NCT05809583
Trial Title Define Predictors of Response to Ozanimod in UC Discovering Biomarkers in the Management of Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: Ozanimod
Participant Information
Sponsor Beth Israel Deaconess Medical Center
City Boston
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2023-05-01
Primary Completion Date 2024-04-01
Completion Date 2024-04-01